Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v7-FR Version v1-EN
Language French English
Date Updated 2021-08-06 2021-05-27
Drug Identification Number 02326078 02326078
Brand name TEVA-AMITRIPTYLINE TEVA-AMITRIPTYLINE
Common or Proper name AMITRIPTYLINE 50MG TAB AMITRIPTYLINE 50MG TAB
Company Name TEVA CANADA LIMITED TEVA CANADA LIMITED
Ingredients AMITRIPTYLINE HYDROCHLORIDE AMITRIPTYLINE HYDROCHLORIDE
Strength(s) 50MG 50MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL ORAL ORAL
Packaging size 100 100
ATC code N06AA N06AA
ATC description ANTIDEPRESSANTS ANTIDEPRESSANTS
Reason for shortage Other (Please describe in comments) Other (Please describe in comments)
Anticipated start date
Actual start date 2021-05-26 2021-05-26
Estimated end date 2021-06-30
Actual end date 2021-07-19
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments Item is discontinued Item is being discontinued
Health Canada comments